InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Smith Mary L., Director. Officer active across 1 companies, notably PTC Therapeutics, INC.. In total, 4 filings have been recorded. The latest transaction was disclosed on 7 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
03,200 shares0
Common Stock
SEC:0001179110-22-000393:0·
03,200 shares0
Common Stock
SEC:0001179110-22-000393·
01,650 shares0
Common Stock
SEC:0001179110-21-006723·
01,650 shares0
Common Stock
SEC:0001179110-21-006723:0·
4 of 4 declarations
About Smith Mary L.
Mary L. Smith serves as a Director of PTC Therapeutics, Inc. In this role, she participates in the governance of the company and strategic decision-making. Mary brings valuable expertise in the sector, thereby enhancing the strategic direction of PTC Therapeutics. Her commitment to innovation is an asset for the company.
